Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

A Phase 2 Study to Assess the Safety and Efficacy of Intravitreal ONL1204 Ophthalmic Solution in Subjects With Mac-off Retinal Detachment

ClinicalTrials.gov ID: NCT05730218

Public ClinicalTrials.gov record NCT05730218. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 7:32 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Randomized, Sham-Controlled, Single-Masked, Dose-Ranging, Multi-Center Study to Assess the Safety and Efficacy of Intravitreal ONL1204 Ophthalmic Solution in Subjects With Macula-off Rhegmatogenous Retinal Detachment

Study identification

NCT ID
NCT05730218
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
ONL Therapeutics
Industry
Enrollment
136 participants

Conditions and interventions

Interventions

  • ONL1204 Ophthalmic Solution Drug
  • Sham treatment Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 3, 2023
Primary completion
Feb 20, 2024
Completion
Feb 20, 2024
Last update posted
Feb 28, 2024

2023 – 2024

United States locations

U.S. sites
36
U.S. states
19
U.S. cities
35
Facility City State ZIP Site status
Associated Retina Consultants Phoenix Arizona 85020
Retina Associates SW PC Tucson Arizona 85704
Win Retina Arcadia California 91006
Global Research Management, Inc. Glendale California 91204
Salehi Retina Institute, Inc. Huntington Beach California 92647
Florida Retina Institute Jacksonville Florida 32216
Florida Retina Consultants Lakeland Florida 33805
Retina Specialty Institute Pensacola Florida 32503
Sarasota Retina Institute Sarasota Florida 34239
Retina Vitreous Associates of Florida St. Petersburg Florida 33711
Retina Specialists of Tampa Wesley Chapel Florida 33544
Marietta Eye Clinic Marietta Georgia 30060
Retina Associates, Ltd. Elmhurst Illinois 60126
Retina Associates, Ltd Elmhurst Illinois 60126
Midwest Eye Institute Carmel Indiana 46290
Cumberland Valley Retina Consultants Hagerstown Maryland 21740
University of Michigan Kellogg Eye Center Ann Arbor Michigan 48105
Mayo Clinic Rochester Minnesota 55905
The Retina Institute St Louis Missouri 63144
Retina Vitreous Surgeons of CNY, PC Liverpool New York 13088
Retina Associates of Western NY, PC Rochester New York 14620
Velocity Clinical Research, Inc. Cincinnati Ohio 45202
Oregon Health & Science University - Casey Eye Institute Portland Oregon 97239
Erie Retina Research, LLC Erie Pennsylvania 16507
Charleston Neuroscience Institute Ladson South Carolina 29456
Palmetto Retina Center, LLC West Columbia South Carolina 29169
Opthalmology Ltd Sioux Falls South Dakota 57108
Southeastern Retina Associates Chattanooga Tennessee 37421
Charles Retina Institute Germantown Tennessee 38138
Retina Research Institute of Texas Abilene Texas 79606
Austin Research Center for Retina Austin Texas 78705
Retina Consultants of Texas Beaumont Texas 77707
Valley Retina Institute, P.A. McAllen Texas 78503
San Antonio Eye Center San Antonio Texas 78215
Retina Consultants of Texas The Woodlands Texas 77384
Retina Center NW, PLLC Silverdale Washington 98383

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05730218, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 28, 2024 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05730218 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →